↓ Skip to main content

Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8+ T cell immunity in CLL and MDS patients

Overview of attention for article published in Frontiers in immunology, January 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
17 Mendeley